Causal inference via propensity scores for case-control studies

📅 2026-08-20
📈 Citations: 0
Influential: 0
📄 PDF
🤖 AI Summary
本文探讨了在病例对照研究中使用倾向评分方法进行因果推断,提出了几种新的估计方法和诊断工具以解决混杂偏差问题。
📝 Abstract
Propensity score methods for causal inference are increasingly being used in cohort and experimental designs, but their development and uptake in outcome-dependent sampling schemes, such as case-control studies, remains limited. Case-control studies involve the sampling of individuals with and without an outcome of interest with the goal of estimating the effects of past exposures. When the design is observational, statistical adjustment for confounding bias is necessary. In case-control studies, propensity score models can be fit using control data under the assumption that the controls are representative of the source population with respect to their exposure distribution conditional on covariates ("control exchangeability"). In this paper, we first demonstrate that relative effects, such as causal risk ratios, are estimable under three different case-control design variants using control-fitted propensity scores. We appropriate two existing estimators for these designs: inverse probability of treatment weighting and an efficient and doubly robust estimator. We also introduce a novel two-step propensity score caliper-matching procedure for case-control designs. We introduce novel diagnostic tools to verify two necessary types of overlap. We then contrast our estimators using simulated data and apply them to examine the association between regular aspirin use and ovarian cancer risk.
Problem

Research questions and friction points this paper is trying to address.

causal inference
propensity scores
case-control studies
confounding bias
Innovation

Methods, ideas, or system contributions that make the work stand out.

propensity score
case-control study
causal inference
overlap diagnostics
caliper-matching
🔎 Similar Papers
💼 Related Jobs
No related jobs found.
Y
Yan Liu
Faculty of Pharmacy, Université de Montréal, QC, Canada
A
Anita Koushik
Department of Oncology, McGill University, QC, Canada; Centre de recherche de St. Mary, QC, Canada
P
Philippe Boileau
Department of Epidemiology, Biostatistics and Occupational Health, McGill University, QC, Canada; Research Institute of the McGill University Health Centre, QC, Canada
C
Cong Jiang
Department of Epidemiology and Biostatistics, SUNY Downstate Health Sciences University, NY, United States
M
Miceline Mésidor
Institut national de la recherche scientifique, Centre Armand-Frappier Santé Biotechnologie, QC, Canada; Faculty of Pharmacy, Université de Montréal, QC, Canada
C
Claudia Waddingham
Centre de recherche de St. Mary, QC, Canada
D
Denis Talbot
Département de médecine sociale et préventive, Université Laval, QC, Canada; Centre de recherche du CHU de Québec – Université Laval, QC, Canada
M
Mireille E. Schnitzer
Faculty of Pharmacy, Université de Montréal, QC, Canada; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, QC, Canada; Département de médecine sociale et préventive, Université de Montréal, QC, Canada